Clinical trial
Firibastat in Treatment-resistant Hypertension
NCT04277884
Study timeline
Study start (actual)2020-06-25Date precision: day
Registry last updated2022-10-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Hypertensionunresolved
Interventions
FiribastatDRUG
PlaceboDRUG
Sponsors & collaborators
Quantum Genomics SAlead sponsor
Mapped research locations
ChicagoIllinois, United States2HoustonTexas, United States1MadridSpain1BirminghamAlabama, United States1CincinnatiOhio, United States1JacksonvilleFlorida, United States1The BronxNew York, United States1PragueCzechia1SarasotaFlorida, United States1Huntington BeachCalifornia, United States1TustinCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04277884 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.